Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Shares Issued (2016 - 2025)

Angiodynamics (ANGO) has disclosed Shares Issued for 16 consecutive years, with $234000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 444.19% year-over-year to $234000.0, compared with a TTM value of $1.1 million through Nov 2025, up 54.23%, and an annual FY2025 reading of $933000.0, up 24.07% over the prior year.
  • Shares Issued was $234000.0 for Q3 2025 at Angiodynamics, down from $895000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $2.0 million in Q1 2021 and bottomed at -$352000.0 in Q4 2023.
  • Average Shares Issued over 5 years is $519125.0, with a median of $428000.0 recorded in 2021.
  • The sharpest move saw Shares Issued soared 9520.0% in 2021, then plummeted 337.84% in 2023.
  • Year by year, Shares Issued stood at $942000.0 in 2021, then plummeted by 84.29% to $148000.0 in 2022, then tumbled by 337.84% to -$352000.0 in 2023, then soared by 98.58% to -$5000.0 in 2024, then surged by 4780.0% to $234000.0 in 2025.
  • Business Quant data shows Shares Issued for ANGO at $234000.0 in Q3 2025, $895000.0 in Q1 2025, and -$5000.0 in Q4 2024.